AlphaYouDS
Insider selling
Daniel S. Lorrain sold $55K of Contineum Therapeutics, Inc. (CTNM) stock
Daniel S. Lorrain, Chief Scientific Officer of Contineum Therapeutics, Inc. (CTNM), sold 4,170 shares of CTNM stock worth $55K, per an SEC Form 4 filed May 1, 2026.
It was an open-market sale.
The trade was reported on May 1, 2026.
CTNM has moved +2.7% since the trade date, from $13.20 to $13.55 (Sep 21, 2026 close).
- Traded
- May 1, 2026
- Disclosed
- May 1, 2026
- Filing delay
- 0 days
- Price since
- +2.7%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4
More CTNM insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.